消喘膏贴敷疗法对稳定期慢性阻塞性肺疾病患者气道炎症的影响
|
摘要
研究目的：
慢性阻塞性肺疾病(Chronic Obstructive Pulmonary Disease, COPD)是呼吸系统常见病、多发病,病情呈进行性发展,目前尚无完全治愈的方法,严重影响患者的劳动能力和生存质量。目前西医对COPD尤其是稳定期的治疗,多是对症治疗；药物治疗的重点只在于改善症状和(或)减少并发症。冬病夏治消喘膏穴位敷贴疗法临床广泛应用于慢性咳喘疾患的防治,广安门医院呼吸科前期工作提示本疗法的在改善慢阻肺稳定期患者生存质量、减少冬季发作次数等发面具有显著的优势,但目前相关作用机制的研究尚欠缺。因此,我们旨在通过对诱导痰气道炎症因子的检测,以期窥探消喘膏治疗的可能作用靶点,为进一步完善和推广消喘膏穴位贴敷技术提供科学实验依据,从一个侧面揭示中医冬病夏治经典理论的科学内涵。
研究方法：
病例资料：按照COPD稳定期中西医诊断标准、纳入标准,纳入56例首次接受贴敷治疗的稳定期COPD门诊患者,随机分为两组,治疗组予以消喘膏贴敷治疗,安慰剂对照组予安慰剂贴敷,贴敷穴位为双侧肺腧(BL13)、心腧(BL15)、膈腧(BL17),每次贴敷6小时,于2009年夏季三伏治疗3次,随访1年。完成病例50例,脱落6例。气道炎症的机制研究：在敷贴前、6个月后分别留取诱导痰样本,制备痰涂片,观察中性粒细胞计数；上清液处理后-70℃保存采用ELISA方法测定IL-8(白细胞介素8)、SIgA(分泌型免疫球蛋白A)、LEP(瘦素)的分泌水平；生活质量研究：第一次敷贴前、敷贴后3、6、12个月分别进行相关问卷调查,主要观察指标包括:St·George's呼吸疾病问卷(SGRQ)、中医证型评分、MMRC评分。
结果：
气道炎症的机制研究：①中性粒细胞计数(COPD气道炎症常见浸润细胞)：治疗组疗后中性粒细胞计数减少优于对照组(P<0.05),对照组疗后中性粒细胞计数无明显变化(P>0.05)。②IL-8、LEP(炎症介质,加重炎症反应)：治疗组诱导痰上清液中IL-8、LEP含量疗后降低(P<0.05),且显著优于对照组,对照组疗后IL-8有所升高(P>0.05)。③SIgA(黏膜免疫蛋白,减少反复感染)：治疗组诱导痰上清液SIgA含量疗后较疗前升高(P<0.05),而对照组略有降低(P<0.05)。生活质量研究：①圣乔治问卷：治疗组敷贴治疗后各项数值均较疗前降低(P<0.05),到冬季又有所升高,对照组与疗前比无明显变化。②MMRC评分：治疗组在疗后12个月评分较疗前降低(P<0.05),余无统计学差异。③中医症状评分：治疗组、对照组的中医症状积分在敷贴治疗后较疗前均有减少(P<0.05),治疗组分值较对照组低,但两组间无统计学差异。无不良反应记录。
结论：
冬病夏治消喘膏穴位贴敷法可增强气道粘膜保护,改善气道慢性炎症,提高COPD,患者生存质量,减轻冬季症状加重,起到对稳定期COPD的治疗作用
Objective:
Chronic Obstructive Pulmonary Disease (COPD) is a common, frequently-occurring and progressive disease. At present, there is no effective treatment measure for COPD, which has seriously affectted the patients'ability of work and quality of life. Up to now, most western medicine treatment to COPD, especially stationary phase, is symptomatic treatment. The focus of therapy is improving symptoms and(or) reducing complications. And traditional Chinese medicine treatment, which named "treatment of wintertime disease in summer by point application with Xiao chuan paste(XCP)", had been widely used in clinical practice. Guang an men hospital pulmonary department had done research before and point out the it can improve COPD patients'life quality and reduce attack frequency in winter. But till lack of co-relational research, especially the study of mechanism of action. Therefore, this research is designed for explore the possible target of "Xiao Chuan paste" cure COPD patients, through component testing of induced sputum. Also could supply scientific experiment evidence for further perfecting and promoting XCP'clinical practice, and reveal the scientific connotation of classical theory "treatment of wintertime disease in summer by point application" from a sideway.
Methods:
Case information:according to the diagnostic and exclusion criteria both in west medicine and TCM,56 COPD patients were randomly divided into two groups (6 expulsions). The treatment group with 30 patients were gave XCP stuck on fei shu (BL13)、xin shu (BL15)、ge shu (BL17) both sides 6 hours every day in dog-days of summer.20 patients in control group were gave placebo stuck on the same points 6hours in the same days as treatment group. Airway inflammation research:before treatment, got every patients'induced sputum,-70℃preserved. After 6-month follow-up, got induced sputum again, and compared with the first-time sputum. The main observed indexes were IL-8、SIgA、LEP、total quantity of inflammatory cell. Quality of life research:before first time paste, did St·George's respiratory disease questionnaire、rating of TCM syndrome type、MMRC score. And did the follow-up again at 3、6、12month. The main point of compare is the change of correlation analysis about follow-up questionnaire index。
Results:
Airway inflammation research:①Inflammation cells(common cell in COPD airway inflammation):The reducing of total quantity of inflammatory cell of treatment group is significantly better than control group(P<0.05), control group do not has obverse change in this index(P>0.05).②IL-8、LEP(mediators of inflammation, which can improve the inflammation):IL-8、LEP in supernatant fluid of induced sputum of control group is decreased obviously(P<0.05) after treatment, and much better than control group, IL-8 of control group even increased(P>0.05);③SIgA(tunicae mucosa immune proteins, reduce frequency of influence):SIgA in supernatant fluid of induced sputum of control group increased after treatment P< 0.05), which was depressed in control group(P<0.05)。Quality of life research:①SGRQ questionnaire:all index of treatment group has decreased after therapy (P<0.05), but they increased some in winter, control group do not has significant change.②MRC score:the grade of treatment group fall down compared to therapy before(P<0.05), after 12 months.③Traditional Chinese medicine symptom score:the grade of both group decreased after treatment(P<0.05), score of treatment group is lower than, control group, but not has statistics difference. There was no adverse reaction.
Conclusion:
Xiao Chuan paste point application treatment could enhance airway mucosal protection, improve the airway chronic inflammation, raise the QOL of COPD patients, lighten the exacerbation in winter, cure COPD patients in stable period at last.
慢性阻塞性肺疾病(Chronic Obstructive Pulmonary Disease, COPD)是呼吸系统常见病、多发病,病情呈进行性发展,目前尚无完全治愈的方法,严重影响患者的劳动能力和生存质量。目前西医对COPD尤其是稳定期的治疗,多是对症治疗；药物治疗的重点只在于改善症状和(或)减少并发症。冬病夏治消喘膏穴位敷贴疗法临床广泛应用于慢性咳喘疾患的防治,广安门医院呼吸科前期工作提示本疗法的在改善慢阻肺稳定期患者生存质量、减少冬季发作次数等发面具有显著的优势,但目前相关作用机制的研究尚欠缺。因此,我们旨在通过对诱导痰气道炎症因子的检测,以期窥探消喘膏治疗的可能作用靶点,为进一步完善和推广消喘膏穴位贴敷技术提供科学实验依据,从一个侧面揭示中医冬病夏治经典理论的科学内涵。
研究方法：
病例资料：按照COPD稳定期中西医诊断标准、纳入标准,纳入56例首次接受贴敷治疗的稳定期COPD门诊患者,随机分为两组,治疗组予以消喘膏贴敷治疗,安慰剂对照组予安慰剂贴敷,贴敷穴位为双侧肺腧(BL13)、心腧(BL15)、膈腧(BL17),每次贴敷6小时,于2009年夏季三伏治疗3次,随访1年。完成病例50例,脱落6例。气道炎症的机制研究：在敷贴前、6个月后分别留取诱导痰样本,制备痰涂片,观察中性粒细胞计数；上清液处理后-70℃保存采用ELISA方法测定IL-8(白细胞介素8)、SIgA(分泌型免疫球蛋白A)、LEP(瘦素)的分泌水平；生活质量研究：第一次敷贴前、敷贴后3、6、12个月分别进行相关问卷调查,主要观察指标包括:St·George's呼吸疾病问卷(SGRQ)、中医证型评分、MMRC评分。
结果：
气道炎症的机制研究：①中性粒细胞计数(COPD气道炎症常见浸润细胞)：治疗组疗后中性粒细胞计数减少优于对照组(P<0.05),对照组疗后中性粒细胞计数无明显变化(P>0.05)。②IL-8、LEP(炎症介质,加重炎症反应)：治疗组诱导痰上清液中IL-8、LEP含量疗后降低(P<0.05),且显著优于对照组,对照组疗后IL-8有所升高(P>0.05)。③SIgA(黏膜免疫蛋白,减少反复感染)：治疗组诱导痰上清液SIgA含量疗后较疗前升高(P<0.05),而对照组略有降低(P<0.05)。生活质量研究：①圣乔治问卷：治疗组敷贴治疗后各项数值均较疗前降低(P<0.05),到冬季又有所升高,对照组与疗前比无明显变化。②MMRC评分：治疗组在疗后12个月评分较疗前降低(P<0.05),余无统计学差异。③中医症状评分：治疗组、对照组的中医症状积分在敷贴治疗后较疗前均有减少(P<0.05),治疗组分值较对照组低,但两组间无统计学差异。无不良反应记录。
结论：
冬病夏治消喘膏穴位贴敷法可增强气道粘膜保护,改善气道慢性炎症,提高COPD,患者生存质量,减轻冬季症状加重,起到对稳定期COPD的治疗作用
Objective:
Chronic Obstructive Pulmonary Disease (COPD) is a common, frequently-occurring and progressive disease. At present, there is no effective treatment measure for COPD, which has seriously affectted the patients'ability of work and quality of life. Up to now, most western medicine treatment to COPD, especially stationary phase, is symptomatic treatment. The focus of therapy is improving symptoms and(or) reducing complications. And traditional Chinese medicine treatment, which named "treatment of wintertime disease in summer by point application with Xiao chuan paste(XCP)", had been widely used in clinical practice. Guang an men hospital pulmonary department had done research before and point out the it can improve COPD patients'life quality and reduce attack frequency in winter. But till lack of co-relational research, especially the study of mechanism of action. Therefore, this research is designed for explore the possible target of "Xiao Chuan paste" cure COPD patients, through component testing of induced sputum. Also could supply scientific experiment evidence for further perfecting and promoting XCP'clinical practice, and reveal the scientific connotation of classical theory "treatment of wintertime disease in summer by point application" from a sideway.
Methods:
Case information:according to the diagnostic and exclusion criteria both in west medicine and TCM,56 COPD patients were randomly divided into two groups (6 expulsions). The treatment group with 30 patients were gave XCP stuck on fei shu (BL13)、xin shu (BL15)、ge shu (BL17) both sides 6 hours every day in dog-days of summer.20 patients in control group were gave placebo stuck on the same points 6hours in the same days as treatment group. Airway inflammation research:before treatment, got every patients'induced sputum,-70℃preserved. After 6-month follow-up, got induced sputum again, and compared with the first-time sputum. The main observed indexes were IL-8、SIgA、LEP、total quantity of inflammatory cell. Quality of life research:before first time paste, did St·George's respiratory disease questionnaire、rating of TCM syndrome type、MMRC score. And did the follow-up again at 3、6、12month. The main point of compare is the change of correlation analysis about follow-up questionnaire index。
Results:
Airway inflammation research:①Inflammation cells(common cell in COPD airway inflammation):The reducing of total quantity of inflammatory cell of treatment group is significantly better than control group(P<0.05), control group do not has obverse change in this index(P>0.05).②IL-8、LEP(mediators of inflammation, which can improve the inflammation):IL-8、LEP in supernatant fluid of induced sputum of control group is decreased obviously(P<0.05) after treatment, and much better than control group, IL-8 of control group even increased(P>0.05);③SIgA(tunicae mucosa immune proteins, reduce frequency of influence):SIgA in supernatant fluid of induced sputum of control group increased after treatment P< 0.05), which was depressed in control group(P<0.05)。Quality of life research:①SGRQ questionnaire:all index of treatment group has decreased after therapy (P<0.05), but they increased some in winter, control group do not has significant change.②MRC score:the grade of treatment group fall down compared to therapy before(P<0.05), after 12 months.③Traditional Chinese medicine symptom score:the grade of both group decreased after treatment(P<0.05), score of treatment group is lower than, control group, but not has statistics difference. There was no adverse reaction.
Conclusion:
Xiao Chuan paste point application treatment could enhance airway mucosal protection, improve the airway chronic inflammation, raise the QOL of COPD patients, lighten the exacerbation in winter, cure COPD patients in stable period at last.
引文
[1]Pin I, Gibson PG, Kolendowicz R, et al.Use of induced sputum cellcounts to investigate airway inflammation in asthma-Thorax,1992,47:25-29.
[2]Fahy JV, Liu J, WongH, et al·Cellular and biochemical analysis ofinduced sputum from asthmatic and from healthy subjects·Am RevRespirDis,1993,147: 1126-1131.
[3]罗炜.诱导痰检测的方法学及其在气道炎症评价中的应用.中国呼吸与危重监护杂志.2008,1,7(6)
[4]纪红,卢翠莲等.沐舒坦诱导痰在老年肺部感染病原体诊断中的意义.第四军医大学学报[J].2007；28(18)
[5]Spanevello A, B eghe B, Bianchi A, et al. Comparison of two methods of processing induced sputum:selected versus entire sputum. Am J Respir Crit Care Med,1998,157:665-668.
[6]齐咏,杨岚.诱导痰在慢性阻塞性肺病气道炎症监测中的应用Journal of Chinese Physician.2004,10,6(12)
[7]赵莹,刘刚,孔灵菲.诱导痰在支气管哮喘气道炎症评价中的应用.中国医科大学学报.2007,2,36(1)
[8]刘凌云,曾勉,左万里等.诱导痰技术在慢性阻塞性肺疾病患者氧化应激机制研究中的应用.中医药指南.2008,8,6(16)
[9]曹文利,孙永昌,盖晓燕,姚婉贞.重度持续性哮喘诱导痰安全性评价.中国呼吸与危重监护杂志.2006,3,5(2)
[10]易阳,钱金强等.诱导痰在急性毛细支气管炎中运用的安全性分析.临床肺科杂志.2009,1,14(1)：130
[11]农光民.诱导痰液技术及其在哮喘临床研究中的作用.中国实用儿科杂志.2009,4,24(4)
[12]魏为利,吕寒静等.自然痰与诱导痰涂片细胞分类计数比较.第四军医大学学报[J].2004,25(21)
[13]POPOV TA, PIZZICHINI MM, PIZZICHINI E, et al. Some technical factors influencing the induction of sputum for cell analysis [J].Eur Respir J, 1995,8(4):559-565.
[14]曹登瑞,丁翠敏.健康成人诱导痰细胞计数正常值参考范围的研究及意义.临床肺科杂志.2008,4,13(4)
[15]蔡柏蔷,李龙芸.协和呼吸病学[M].北京：中国协和医科大学出版社.2005：921.
[16]曹玉芝.诱导痰技术在肺癌细胞学诊断中的应用.中国医药指南.2009,6,7(11)
[17]卢珊珊等.痰细胞学在肺癌诊断中的应用研究进展.中国肺癌杂志.2009,5,12(5)
[18]申宝红,王建玲.诱导痰检测技术在无痰肺结核诊断中的临床应用.中国医药导报.2008,1,5(2)
[19]王先广,朱琥.诱导痰细胞学分析对咳嗽变异型哮喘的诊断价值.武汉大学学报.2007,3,28(2)
[20]唐以军,徐永健等.动态监测哮喘患者诱导痰嗜酸性粒细胞的临床意义.临床内科杂志.2003,9,20(9)
[21]曾勉,刘凌云等.各期慢性阻塞性肺疾病患者诱导痰细胞成分与肺功能的关系.中山大学学报.2007,7,28(4)
[22]刘振奎等.喘息型肺炎患儿诱导痰涂片细胞分类计数改变特征.河北北方学院学报.2007,6,24(3)
[23]蔡泽民,杨云华.小儿哮喘急性发作期诱导痰Th1/Th2细胞因子的研究.基层医学论坛.2008,12,12.(上旬刊)
[24]徐少华,王伟等.超短波治疗对COPD患者诱导痰中炎症细胞及IL-8和TNF-α的影响.华物理医学与康复杂志.2005,3,27(3)
[25]胡正强,江咏梅SIgA基础与临床研究进展.免疫学杂志.2003,6,19(3)
[26]陆婉秋.儿童支气管哮喘与唾液中SIgA相关性初步研究.细胞与分子免疫学杂志.2009,25(8)
[27]谢汉华,甘丹,陈霞.气道分泌液瘦素测定对慢性阻塞性肺疾病危重患者的评估意义.中国医师杂志.2006年增刊.272-273
[28]医药与保健,2007年,11,pg5
[29]张丹婷.慢性阻塞性肺疾病的中医病机探讨.海南医学院学报.2009,4,15(4),385-386
[30]段晨霞.浅谈冬病夏治.江西中医药.2009年,314,2(2)
[31]陆军.说话冬病夏治[J].中国中医药报,2004,(6)：7.
[32]郑彩霞,王洪刚,刘振安.穴位贴敷为主治疗慢性阻塞性肺疾病90例.中医研究.2005,18(10)：36-37
[33]赭文浩,膝松茂,张彦.“冬病夏治”防治老年人慢性支气管炎[J].上海针灸杂志.2001,20(3)：8-9.
[34]宋南昌,熊润贤.天灸膏敷贴对100例慢性支气管炎冬病夏治的疗效观察[J].江西中医药.1994,27(4)：4
[35]田丰.壮肺膏敷贴治疗慢性支气管炎200例[J].山西中医.1998,14(6)：37.
[36]王燕,方清信.哮喘停穴位敷贴治疗慢性支气管炎99例[J].山东中医杂志.1999,18(3)：111-113.
[37]郑爱红,高洁.穴位贴敷治疗慢性咳喘疗效观察.河北中医.2009年4月,31(4)
[38]李国勤,边永君,李光熙,刘丽,李辉,王蕾,金在艳,刘志国,刘俊玲,刘世刚,花宝金.冬病夏治消喘膏治疗慢性肺系疾病的回顾性研究.北京中医药.2008年,11月,27(11)
[39]Aiber M K, et al. Skin Permeability:Dermatology aspect of Trans-dermal drug delivery[J].AmHeart,1984,10(8):200.
[40]V yas S P.et al. Development and characterization of Pseudolater based transdermal srug delivery system or diclofenal[J], Drug Derlnd Pharm,1991, 17(7):1041.
[41]沈利华.支气管哮喘的冬病夏治临床研究[J].实用中医药杂志2001,17(4)：3-4.
[42]史宇广,单书健.当代名医临证精华.咳喘专辑[M].北京：中国古籍出版社,1988.123.
[43]方剑乔,刘金洪,赵天征等.斑蝥穴位敷贴治疗小鼠胶原性关节炎的初步观察[J].浙江中医学院学报.2000,13(1)：72-74.
[44]壮健.消喘膏贴敷对哮喘豚鼠Thl/Th2类细胞因子的影响[J].四川中医,2003,21(6)：13-14
[45]孙德利,章明,陈汉平等.天灸后环磷酰胺小鼠血清对淋巴细胞增殖效应的影响[J].上海中医药大学学报.2000,14(4)：43-48.
[46]唐岚,刘力.中医药治疗慢性阻塞性肺疾病研究进展.中华实用中西医杂志.2005；18(7)：1013-1015
[47]Janeway CA. Travers P, Hunt S, et al. Host defense against infection. In:Immunology; The immune system in health and disease[M].3rd London; Current Biology Publication,1993.31-48
[48]林云璐.免疫应答的生物学基础[A].见：陈灏珠,主编.实用内科学第10版,北京：人民卫生出版社,1999.31-48
[49]吴辉祖.呼吸系统的免疫功能[A].见：崔祥滨,主编.实用肺脏病学[M].上海：上海科学技术出版社,1992.53-64
[50]王伟,徐少华,柳相珍,邵红艳.慢性阻塞性肺疾病急性发作期外周血及痰中IL-8和TNF-α测定的意义.现代免疫杂志.2004 24(1)：63-65
[51]Keatings VM, Co llins PD, Sco tt DM, et al. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients w ith chronic obstructive pulmonary disease or asthma AmJ Resp ir rit CareM ed, 1996; 153 (2):530-534.
[52]袁益明,王曾礼,刘春涛.血清瘦素对慢性阻塞性肺疾病患者营养状态影响的初步研究.中华结核和呼吸杂志.2000,23(5)：292-295.
[53]Bruno A, Chanez P, Chiappara G, et a.l Does leptin play a cytokine-like role within the airways of COPD patients? Eur Respir J,2005,26(3):398-405.
[54]潘海燕,卢小卓,汪得喜,等.慢性阻塞性肺疾病患者急性加重期瘦素的表达及作用.中国实用内科杂志.2006,1：39-41.
[55]曹照龙,何权瀛.分泌型sIgA与慢性呼吸道疾病.中国慢性病预防与控制.2004；12(3)：140-142
[2]Fahy JV, Liu J, WongH, et al·Cellular and biochemical analysis ofinduced sputum from asthmatic and from healthy subjects·Am RevRespirDis,1993,147: 1126-1131.
[3]罗炜.诱导痰检测的方法学及其在气道炎症评价中的应用.中国呼吸与危重监护杂志.2008,1,7(6)
[4]纪红,卢翠莲等.沐舒坦诱导痰在老年肺部感染病原体诊断中的意义.第四军医大学学报[J].2007；28(18)
[5]Spanevello A, B eghe B, Bianchi A, et al. Comparison of two methods of processing induced sputum:selected versus entire sputum. Am J Respir Crit Care Med,1998,157:665-668.
[6]齐咏,杨岚.诱导痰在慢性阻塞性肺病气道炎症监测中的应用Journal of Chinese Physician.2004,10,6(12)
[7]赵莹,刘刚,孔灵菲.诱导痰在支气管哮喘气道炎症评价中的应用.中国医科大学学报.2007,2,36(1)
[8]刘凌云,曾勉,左万里等.诱导痰技术在慢性阻塞性肺疾病患者氧化应激机制研究中的应用.中医药指南.2008,8,6(16)
[9]曹文利,孙永昌,盖晓燕,姚婉贞.重度持续性哮喘诱导痰安全性评价.中国呼吸与危重监护杂志.2006,3,5(2)
[10]易阳,钱金强等.诱导痰在急性毛细支气管炎中运用的安全性分析.临床肺科杂志.2009,1,14(1)：130
[11]农光民.诱导痰液技术及其在哮喘临床研究中的作用.中国实用儿科杂志.2009,4,24(4)
[12]魏为利,吕寒静等.自然痰与诱导痰涂片细胞分类计数比较.第四军医大学学报[J].2004,25(21)
[13]POPOV TA, PIZZICHINI MM, PIZZICHINI E, et al. Some technical factors influencing the induction of sputum for cell analysis [J].Eur Respir J, 1995,8(4):559-565.
[14]曹登瑞,丁翠敏.健康成人诱导痰细胞计数正常值参考范围的研究及意义.临床肺科杂志.2008,4,13(4)
[15]蔡柏蔷,李龙芸.协和呼吸病学[M].北京：中国协和医科大学出版社.2005：921.
[16]曹玉芝.诱导痰技术在肺癌细胞学诊断中的应用.中国医药指南.2009,6,7(11)
[17]卢珊珊等.痰细胞学在肺癌诊断中的应用研究进展.中国肺癌杂志.2009,5,12(5)
[18]申宝红,王建玲.诱导痰检测技术在无痰肺结核诊断中的临床应用.中国医药导报.2008,1,5(2)
[19]王先广,朱琥.诱导痰细胞学分析对咳嗽变异型哮喘的诊断价值.武汉大学学报.2007,3,28(2)
[20]唐以军,徐永健等.动态监测哮喘患者诱导痰嗜酸性粒细胞的临床意义.临床内科杂志.2003,9,20(9)
[21]曾勉,刘凌云等.各期慢性阻塞性肺疾病患者诱导痰细胞成分与肺功能的关系.中山大学学报.2007,7,28(4)
[22]刘振奎等.喘息型肺炎患儿诱导痰涂片细胞分类计数改变特征.河北北方学院学报.2007,6,24(3)
[23]蔡泽民,杨云华.小儿哮喘急性发作期诱导痰Th1/Th2细胞因子的研究.基层医学论坛.2008,12,12.(上旬刊)
[24]徐少华,王伟等.超短波治疗对COPD患者诱导痰中炎症细胞及IL-8和TNF-α的影响.华物理医学与康复杂志.2005,3,27(3)
[25]胡正强,江咏梅SIgA基础与临床研究进展.免疫学杂志.2003,6,19(3)
[26]陆婉秋.儿童支气管哮喘与唾液中SIgA相关性初步研究.细胞与分子免疫学杂志.2009,25(8)
[27]谢汉华,甘丹,陈霞.气道分泌液瘦素测定对慢性阻塞性肺疾病危重患者的评估意义.中国医师杂志.2006年增刊.272-273
[28]医药与保健,2007年,11,pg5
[29]张丹婷.慢性阻塞性肺疾病的中医病机探讨.海南医学院学报.2009,4,15(4),385-386
[30]段晨霞.浅谈冬病夏治.江西中医药.2009年,314,2(2)
[31]陆军.说话冬病夏治[J].中国中医药报,2004,(6)：7.
[32]郑彩霞,王洪刚,刘振安.穴位贴敷为主治疗慢性阻塞性肺疾病90例.中医研究.2005,18(10)：36-37
[33]赭文浩,膝松茂,张彦.“冬病夏治”防治老年人慢性支气管炎[J].上海针灸杂志.2001,20(3)：8-9.
[34]宋南昌,熊润贤.天灸膏敷贴对100例慢性支气管炎冬病夏治的疗效观察[J].江西中医药.1994,27(4)：4
[35]田丰.壮肺膏敷贴治疗慢性支气管炎200例[J].山西中医.1998,14(6)：37.
[36]王燕,方清信.哮喘停穴位敷贴治疗慢性支气管炎99例[J].山东中医杂志.1999,18(3)：111-113.
[37]郑爱红,高洁.穴位贴敷治疗慢性咳喘疗效观察.河北中医.2009年4月,31(4)
[38]李国勤,边永君,李光熙,刘丽,李辉,王蕾,金在艳,刘志国,刘俊玲,刘世刚,花宝金.冬病夏治消喘膏治疗慢性肺系疾病的回顾性研究.北京中医药.2008年,11月,27(11)
[39]Aiber M K, et al. Skin Permeability:Dermatology aspect of Trans-dermal drug delivery[J].AmHeart,1984,10(8):200.
[40]V yas S P.et al. Development and characterization of Pseudolater based transdermal srug delivery system or diclofenal[J], Drug Derlnd Pharm,1991, 17(7):1041.
[41]沈利华.支气管哮喘的冬病夏治临床研究[J].实用中医药杂志2001,17(4)：3-4.
[42]史宇广,单书健.当代名医临证精华.咳喘专辑[M].北京：中国古籍出版社,1988.123.
[43]方剑乔,刘金洪,赵天征等.斑蝥穴位敷贴治疗小鼠胶原性关节炎的初步观察[J].浙江中医学院学报.2000,13(1)：72-74.
[44]壮健.消喘膏贴敷对哮喘豚鼠Thl/Th2类细胞因子的影响[J].四川中医,2003,21(6)：13-14
[45]孙德利,章明,陈汉平等.天灸后环磷酰胺小鼠血清对淋巴细胞增殖效应的影响[J].上海中医药大学学报.2000,14(4)：43-48.
[46]唐岚,刘力.中医药治疗慢性阻塞性肺疾病研究进展.中华实用中西医杂志.2005；18(7)：1013-1015
[47]Janeway CA. Travers P, Hunt S, et al. Host defense against infection. In:Immunology; The immune system in health and disease[M].3rd London; Current Biology Publication,1993.31-48
[48]林云璐.免疫应答的生物学基础[A].见：陈灏珠,主编.实用内科学第10版,北京：人民卫生出版社,1999.31-48
[49]吴辉祖.呼吸系统的免疫功能[A].见：崔祥滨,主编.实用肺脏病学[M].上海：上海科学技术出版社,1992.53-64
[50]王伟,徐少华,柳相珍,邵红艳.慢性阻塞性肺疾病急性发作期外周血及痰中IL-8和TNF-α测定的意义.现代免疫杂志.2004 24(1)：63-65
[51]Keatings VM, Co llins PD, Sco tt DM, et al. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients w ith chronic obstructive pulmonary disease or asthma AmJ Resp ir rit CareM ed, 1996; 153 (2):530-534.
[52]袁益明,王曾礼,刘春涛.血清瘦素对慢性阻塞性肺疾病患者营养状态影响的初步研究.中华结核和呼吸杂志.2000,23(5)：292-295.
[53]Bruno A, Chanez P, Chiappara G, et a.l Does leptin play a cytokine-like role within the airways of COPD patients? Eur Respir J,2005,26(3):398-405.
[54]潘海燕,卢小卓,汪得喜,等.慢性阻塞性肺疾病患者急性加重期瘦素的表达及作用.中国实用内科杂志.2006,1：39-41.
[55]曹照龙,何权瀛.分泌型sIgA与慢性呼吸道疾病.中国慢性病预防与控制.2004；12(3)：140-142